SUNESIS PHARMACEUTICALS INC
SUNESIS PHARMACEUTICALS INC (SNSS) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 230 transactions totaling $163.3M, demonstrating a bearish sentiment with -$12.1M in net insider flow. The most recent transaction on Feb 28, 2024 involved a transaction of 3,747 shares valued at $24.5K.
SNSS Insider Activity Summary
Who Is Buying SNSS Stock?
No significant insider buying has been recorded for SNSS in the recent period.
Who Is Selling SNSS Stock?
No significant insider selling has been recorded for SNSS in the recent period.
Is SUNESIS PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SNSS is bearish with an Insider Alignment Score of 46/100 and a net flow of -$12.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SNSS Frequently Asked Questions
Understanding SNSS Insider Activity
Insider trading at SUNESIS PHARMACEUTICALS INC (SNSS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading SNSS stock, having executed 230 transactions in the past 90 days. The most active insider is Dayton Misfeldt (Executive), who has made 26 transactions totaling $20.7M.
Related Tools
Track SUNESIS PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at SNSS file new Form 4 transactions